the aid library

LIST OPTIONS

Filter

10264

A comparative analysis of national HIV policies in six African countries with generalized epidemics

K. Church; F. Kiweewa, A.Dasgupta; et al. Bull World Health Organ; PMC (US National Library of Medicine National Institutes of Health) (2015) C2

Bull World Health Organ 2015;93:457–467 | doi: http://dx.doi.org/10.2471/BLT.14.147215

Download (269)

View PDF (277)

Spirituality in Nursing

Ruder, S. (2013) CC

Nurses' perceptions about providing spiritual care

Download (237)

View PDF (308)

Zero maternal deaths from obstetric emergencies

World Health Organisation (WHO) (2023) C_WHO

This document contains the main points of the zero maternal deaths from obstetric emergencies initiative.

Download (393)

View PDF (297)

Preparedness and Response for a Nuclear or Radiological Emergency Combined with Other Incidents or Emergencies

International Atomic Energy Agency IAEA, WHO; OCHA; ET al. (2020) C_WHO

IAEA Safety Standards for protecting people and the environment

Download (1105)

View PDF (762)

A Strategic Framework for Emergency Preparedness

World Health Organization (WHO) (2017) C_WHO

The Strategic Framework for Emergency Preparedness is a unifying framework which identifies the principles and elements of effective country health emergency preparedness. It adopts the major lessons of previous initiatives and lays out the planning and implementation process by which countries can ... more

Download (3084)

View PDF (1768)

Kenya :National Strategic Plan for Eye Help and Blindness Prevention: 2012-2018

Ophthalmic Services Unit (2012) C1

Download (929)

View PDF (2500)

Gender-based violence and child protection among Syrian refugees in Jordan, with a focus on early marriage

UNWomen (2013)

Findings from this report reveal that, rates of early marriage are high, a significant percentage of children contribute to the household’s income or are its main source of income, and restrictions on the mobility of women and girls constrain their participation in social and economic activities a... more

Download (395)

View PDF (805)

Water sanitation and hygiene for accelerating and sustaining progress on neglected tropical diseases: A global strategy 2015-2020

World Health Organization (WHO) (2015) C_WHO

Water, sanitation and hygiene (WASH) are critical in the prevention and care for all of the 17 neglected tropical diseases (NTDs) scheduled for intensified control or elimination by 2020.
Provision of safe water, sanitation and hygiene is one of the five key interventions within the global NTD ... more

Download (255)

View PDF (251)

Principles in using psychotropic medication in children and adolescents

B. Vitiello IACAPAP (2012) C2

Introduction Chapter A.7

Download (251)

View PDF (211)

Guidelines for Care of Children in the Emergency Department

AAP, ACEP, ENA, the EMSC National Resource Center, and Children’s National Medical Center USA (2009) C1

Download (441)

View PDF (680)

Facility based integrated management of neonatal and childhood illness (F-IMNCI) - Facilitators Guide (Facility Based Care)

Ministry of Health and Family Welfare Government of India; WHO; UNICEF (2009) C_WHO

Download (216)

View PDF (225)

TB Advocacy Guide - For People who use Drugs

hit.org.uk; INPUD (2019) C2

Accessed: 19.10.2019

Download (369)

View PDF (533)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (1626)

View PDF (1864)

A Framework for Integrating Childhood Tuberculosis into Community-based Child Health Care

Detjen A, Gnanashanmugam D, Talens A International Union Against Tuberculosis and Lung Disease (The Union), CORE Group (2013) C_WHO

Download (696)

View PDF (872)

Brief, structured psychological treatment

World Health Organization WHO (2012) C_WHO

Q 3: Is brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with depressive episode/disorder?

Download (757)

View PDF (750)

Infection Prevention and control and health care waste management for waste handlers

USAID, AIDS Free Nigeria (2016) C1

AIDS Free Nigeria Training Manual

Download (814)

View PDF (1419)

National Strategic Framework for the Elimination of Obstetrics Fistula in Nigeria 2011-2015

Federal Ministry of Health, Nigeria (2012) C1

Download (597)

View PDF (1250)

International technical guidance on sexuality education. An evidence-informed approach.

UNESCO (2018) CC

This revised and fully updated edition of the International technical guidance on sexuality education benefits from a new review of the current evidence, and reaffirms the position of sexuality education within a framework of human rights and gender equality. It promotes structured learning about... more

Download (369)

View PDF (577)

Toolkit on disability for AFRICA: CULTURE, BELIEFS, AND DISABILITY

United Nations Division for Social Policy Development (DSPD) & United Nations Department of Economic and Social Affairs (DESA) (2016) C1

Module 13

Download (191)

View PDF (280)

Strategic Considerations for Mitigating the Impact of COVID-19 on Key Population-Focused HIV Programs

FHI 360; UNAIDS reliefweb (2020) C2

The COVID-19 pandemic has affected everyone, including key populations at higher risk of HIV. And the gains made against other infectious diseases, including HIV, are at risk of being reversed as a result of disruptions caused by COVID-19. This is the background to a new report published by FHI 360,... more